MedPath

Found 549574 clinical trials

Sort by:

Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD

Not Applicable

Not yet recruiting

Conditions: IBD (Inflammatory Bowel Disease)
IBD
IBD - Inflammatory Bowel Disease

First Posted Date: 2025-08-14

Last Posted Date: 2025-08-14

Lead Sponsor: Cook Children's Health Care System

Target Recruit Count: 40

Registration Number: NCT07121920

Locations: 🇺🇸
University of Texas at Arlington, Arlington, Texas, United States
🇺🇸
Cook Children's Health Care System, Fort Worth, Texas, United States

Implementing a Therapy for Complex Trauma in French-Speaking Settings

Not Applicable

Completed

Conditions: Borderline Personality Disorder (BPD)
Complex Post-Traumatic Stress Disorder (CPTSD)
Post-Traumatic Stress Disorder, PTSD

First Posted Date: 2025-08-14

Last Posted Date: 2025-08-14

Lead Sponsor: Ciusss de L'Est de l'Île de Montréal

Target Recruit Count: 15

Registration Number: NCT07123974

Locations: 🇨🇦
Institut universitaire en santé mentale de Montréal, Montréal, Quebec, Canada

GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases

Not Applicable

Not yet recruiting

Conditions: Autoimmune Diseases

Interventions: Biological: GT719 Injection

First Posted Date: 2025-08-14

Last Posted Date: 2025-08-14

Lead Sponsor: Grit Biotechnology

Target Recruit Count: 10

Registration Number: NCT07122076

Locations: 🇨🇳
Shanghai Changzheng Hospital, Shanghai, China

Monitoring the Response of Combination Ursodiol and Seladelpar Treatment

Not yet recruiting

Conditions: Primary Biliary Cholangitis

First Posted Date: 2025-08-14

Last Posted Date: 2025-08-14

Lead Sponsor: Methodist Health System

Target Recruit Count: 100

Registration Number: NCT07122206

Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation

Not Applicable

Recruiting

Conditions: Persistent Atrial Fibrillation

First Posted Date: 2025-08-14

Last Posted Date: 2025-08-14

Lead Sponsor: Shanghai Chest Hospital

Target Recruit Count: 384

Registration Number: NCT07122336

Locations: 🇨🇳
Shanghai Chest Hospital, Shanghai, China

Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure

Not Applicable

Not yet recruiting

Conditions: Atrial Fibrillation
Atrial Flutter
Tachycardia, Supraventricular
Heart Septal Defects, Atrial

Interventions: Drug: Beta-blocker treatment group
Drug: Non-treatment group

First Posted Date: 2025-08-14

Last Posted Date: 2025-08-14

Lead Sponsor: Yonsei University

Target Recruit Count: 350

Registration Number: NCT07123506

Locations: 🇰🇷
Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea, Republic of

To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia

Not Applicable

Conditions: Chronic Postoperative Neuralgia

Interventions: Drug: TRD205 tablets
Drug: Placebo

First Posted Date: 2025-08-14

Last Posted Date: 2025-08-14

Lead Sponsor: Beijing Tide Pharmaceutical Co., Ltd

Target Recruit Count: 184

Registration Number: NCT07123402

Locations: 🇨🇳
China-Japan Friendship Hospital, Beijing, China

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Not Applicable

Recruiting

Conditions: Solid Tumors

Interventions: Drug: XB371

First Posted Date: 2025-08-14

Last Posted Date: 2025-08-14

Lead Sponsor: Exelixis

Target Recruit Count: 150

Registration Number: NCT07123103

Locations: 🇺🇸
Exelixis Clinical Site #1, San Antonio, Texas, United States

Cross-sectional Study of Sleep Disturbance in Hong Kong Children With Cancer Comparing With Healthy Counterparts and Children With Other Chronic Diseases

Recruiting

Conditions: Sleep
Sleep Disturbances in Children
Sleep Disturbances

First Posted Date: 2025-08-14

Last Posted Date: 2025-08-14

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 150

Registration Number: NCT07122921

Locations: 🇭🇰
Hong Kong Children's Hospital, Hong Kong, Hong Kong

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of an Oral Supplement in Supporting Vision and Eye Health

Not Applicable

Completed

Conditions: Dry Eye
Eye Fatigue

First Posted Date: 2025-08-14

Last Posted Date: 2025-08-14

Lead Sponsor: Bio Nature Health

Target Recruit Count: 60

Registration Number: NCT07123584

Locations: 🇺🇸
Citruslabs, Las Vegas, Nevada, United States

AI-Powered Research

Premium Access

Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD

Implementing a Therapy for Complex Trauma in French-Speaking Settings

GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases

Monitoring the Response of Combination Ursodiol and Seladelpar Treatment

Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation

Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure

To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Cross-sectional Study of Sleep Disturbance in Hong Kong Children With Cancer Comparing With Healthy Counterparts and Children With Other Chronic Diseases

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of an Oral Supplement in Supporting Vision and Eye Health

Product

Company

Legal